MindWalk Holdings (HYFT) Goodwill & Intangibles (2020 - 2025)
MindWalk Holdings (HYFT) posted quarterly Goodwill & Intangibles of $6.5 million for Q2 2025, down 80.94% year-over-year from $34.3 million in Q2 2024, and up 3.11% quarter-over-quarter from $6.3 million in Q1 2025.
MindWalk Holdings (HYFT) Goodwill & Intangibles (2020 - 2025) Analysis & Trends
MindWalk Holdings (HYFT) has reported Goodwill & Intangibles for 6 consecutive years, with $6.5 million the latest figure, recorded in Q2 2025.
- In Q2 2025, Goodwill & Intangibles fell 80.94% year-over-year to $6.5 million; the TTM figure through Apr 2025 stood at $6.5 million (down 80.94% YoY), while the FY2025 annual figure was $6.7 million, down 80.62% from the prior year.
- Goodwill & Intangibles climbed to $6.5 million in Q2 2025 per HYFT's latest filing, from $6.3 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $46.8 million in Q2 2022 and bottomed at $6.3 million in Q1 2025.
- Historically, Goodwill & Intangibles has averaged $25.8 million across 5 years, with a median of $28.6 million in 2024.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles surged 312.27% — and 2025, when it sank 81.59%.
- MindWalk Holdings' Goodwill & Intangibles stood at $9.8 million in 2021, then surged by 282.37% to $37.6 million in 2022, then slipped by 6.1% to $35.3 million in 2023, then tumbled by 35.86% to $22.6 million in 2024, then slumped by 71.15% to $6.5 million in 2025.
- Business Quant data shows HYFT's Goodwill & Intangibles at $6.5 million in Q2 2025, $6.3 million in Q1 2025, and $22.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 6.53 Mn |
| Jan 31, 2025 | 6.34 Mn |
| Oct 31, 2024 | 22.65 Mn |
| Jul 31, 2024 | 22.84 Mn |
| Apr 30, 2024 | 34.27 Mn |
| Jan 31, 2024 | 34.41 Mn |
| Oct 31, 2023 | 35.31 Mn |
| Jul 31, 2023 | 36.04 Mn |
| Apr 30, 2023 | 46.40 Mn |
| Jan 31, 2023 | 39.00 Mn |
| Oct 31, 2022 | 37.60 Mn |
| Jul 31, 2022 | 38.23 Mn |
| Apr 30, 2022 | 46.78 Mn |
| Jan 31, 2022 | 9.46 Mn |
| Oct 31, 2021 | 9.83 Mn |
| Jul 31, 2021 | 10.81 Mn |
| Apr 30, 2021 | 15.63 Mn |
| Jan 31, 2021 | 11.92 Mn |
| Oct 31, 2020 | 12.02 Mn |
| Apr 30, 2020 | 14.62 Mn |